OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
300766 Merit Interactive
- 40.41
- -1.01-2.44%
Market Closed Apr 1 15:00 CST
15.85BMarket Cap-244.91P/E (TTM)
41.77High40.28Low378.79KlotVolume41.66Open41.42Pre Close1.54BTurnover10.65%Turnover RatioLossP/E (Static)392.17MShares70.5052wk High10.11P/B14.37BFloat Cap8.7752wk Low49.70Limit Up355.67MShs Float74.80Historical High33.14Limit Down3.60%Amplitude7.75Historical Low--Dividend TTM40.69Avg Price186.62KlotAsk--Div YieldTTM100Lot Size165.63KlotBid
Merit Interactive Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 9.41%470.36M | 7.55%333.32M | 2.44%217.02M | -6.57%100.15M | -18.25%429.91M | -20.18%309.93M | -25.04%211.85M | -32.94%107.19M | -12.43%525.9M | -9.01%388.27M |
| Operating revenue | 9.41%470.36M | 7.55%333.32M | 2.44%217.02M | -6.57%100.15M | -18.25%429.91M | -20.18%309.93M | -25.04%211.85M | -32.94%107.19M | -12.43%525.9M | -9.01%388.27M |
| Other operating revenue | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- |
| Total operating cost | -2.16%458.62M | 3.46%324.13M | 3.02%212.3M | 3.37%104.06M | -5.50%468.77M | -12.61%313.3M | -16.35%206.07M | -25.38%100.66M | -1.88%496.04M | -0.09%358.52M |
| Operating cost | -7.29%125.26M | -11.49%79.96M | -22.33%48.67M | -34.47%22.16M | -30.83%135.11M | -29.63%90.34M | -32.70%62.67M | -39.74%33.82M | -8.48%195.33M | -15.82%128.38M |
| Operating tax surcharges | 62.83%5.3M | 171.00%3.62M | 138.15%2.32M | 153.18%1.25M | 9.24%3.25M | -11.20%1.34M | -6.78%972.41K | -10.76%495.05K | -3.02%2.98M | -20.66%1.5M |
| Operating expense | 16.66%97.85M | 21.29%69.62M | 21.50%45.9M | 23.66%21.05M | -3.63%83.88M | -9.10%57.4M | -13.72%37.78M | -23.86%17.02M | -5.51%87.03M | -0.14%63.14M |
| Administration expense | 11.95%129.18M | 25.72%92.15M | 32.30%61.69M | 54.09%33.03M | 27.69%115.4M | -2.73%73.3M | -6.82%46.63M | -12.99%21.44M | -5.52%90.37M | 9.34%75.35M |
| Financial expense | 51.61%-11.9M | 51.15%-9.46M | 49.44%-6.89M | 42.65%-3.88M | 20.02%-24.59M | 17.84%-19.36M | 11.20%-13.62M | 10.11%-6.76M | -13.37%-30.75M | -17.39%-23.57M |
| -Interest expense (Financial expense) | 579.84%331K | --82.27K | --61.08K | --34.98K | 27.32%48.69K | ---- | ---- | ---- | -92.13%38.24K | --52.2K |
| -Interest Income (Financial expense) | 50.48%-12.18M | 50.09%-9.6M | 48.01%-6.93M | 42.28%-3.94M | 18.21%-24.6M | 15.35%-19.24M | 11.09%-13.32M | 10.18%-6.83M | -7.84%-30.07M | -12.44%-22.73M |
| Research and development | -27.49%112.93M | -19.99%88.25M | -15.41%60.6M | -12.17%30.43M | 3.08%155.73M | -3.00%110.3M | -2.81%71.64M | -10.59%34.65M | 17.63%151.08M | 23.11%113.71M |
| Credit Impairment Loss | -20.77%-12.21M | -49.47%-9.04M | -37.66%-5.68M | 0.09%-3.11M | -87.59%-10.11M | 10.33%-6.05M | 7.40%-4.12M | 1.65%-3.11M | 17.02%-5.39M | -40.75%-6.75M |
| Asset Impairment Loss | -462.86%-349.96K | -65.27%-57.2K | -334.65%-57.2K | ---- | 156.82%96.45K | -44.12%-34.61K | 45.20%-13.16K | 73.80%-13.16K | -1,464.27%-169.75K | -265.44%-24.02K |
| Other net revenue | 124.53%3.82M | 42.46%-2.55M | 143.46%949.04K | 72.49%-1.62M | -280.08%-15.58M | -679.89%-4.44M | -283.04%-2.18M | -55.03%-5.89M | -76.50%8.65M | -97.75%765.04K |
| Fair value change income | 58.10%-6.24M | --917.57K | --917.57K | ---- | -402.70%-14.9M | ---- | ---- | ---- | -4.34%4.92M | -4.34%4.92M |
| Invest income | 231.38%12.69M | 224.06%3.17M | 404.78%3.36M | 86.56%-647.91K | 739.34%3.83M | 44.19%-2.55M | 80.55%-1.1M | -12.21%-4.82M | -98.35%456.34K | -117.01%-4.57M |
| -Including: Investment income associates | 179.78%10.67M | 208.33%2.76M | 396.06%3.27M | 86.56%-647.91K | 297.52%3.81M | 63.34%-2.55M | 80.55%-1.1M | -12.21%-4.82M | -40.66%-1.93M | -218.86%-6.96M |
| Asset deal income | -96.68%4.23K | --4.23K | --3.38K | --3.38K | --127.47K | ---- | ---- | ---- | ---- | ---- |
| Other revenue | 84.73%9.92M | -41.45%2.46M | -21.42%2.4M | 3.88%2.13M | -39.17%5.37M | -41.56%4.2M | -52.37%3.06M | -44.65%2.05M | -15.83%8.83M | 5.39%7.18M |
| Operating profit | 128.58%15.56M | 184.93%6.63M | 57.82%5.67M | -974.48%-5.53M | -241.36%-54.44M | -125.60%-7.81M | -90.40%3.59M | -97.01%632.25K | -70.78%38.51M | -70.08%30.51M |
| Add:Non operating Income | --0 | --0 | ---- | ---- | -78.90%1.1K | --0 | ---- | ---- | -98.02%5.21K | ---- |
| Less:Non operating expense | 334.80%93.45M | 2,751.54%5.03M | 1,557.15%2.66M | -99.97%6.48 | 351.73%21.49M | -96.08%176.57K | -95.99%160.77K | -99.07%18.64K | 49.01%4.76M | 984.07%4.51M |
| Total profit | -2.58%-77.89M | 120.01%1.6M | -12.39%3.01M | -1,001.04%-5.53M | -324.93%-75.93M | -130.71%-7.99M | -89.73%3.43M | -96.79%613.61K | -73.81%33.76M | -74.46%26M |
| Less:Income tax cost | 58.26%-9.51M | 61.19%-4.32M | 69.43%-2.26M | -41.54%-2.85M | -575.09%-22.77M | -559.12%-11.13M | -380.83%-7.41M | -371.14%-2.02M | -35.53%4.79M | -56.23%2.43M |
| Net profit | -28.65%-68.39M | 88.01%5.92M | -51.37%5.27M | -201.68%-2.67M | -283.53%-53.16M | -86.65%3.15M | -64.81%10.84M | -85.71%2.63M | -76.15%28.96M | -75.51%23.58M |
| Net profit from continuing operation | -28.65%-68.39M | 88.01%5.92M | -51.37%5.27M | -201.68%-2.67M | -283.53%-53.16M | -86.65%3.15M | -64.81%10.84M | -85.71%2.63M | -76.15%28.96M | -75.51%23.58M |
| Less:Minority Profit | -12.55%-3.63M | -116.23%-427K | -61.17%1.12M | 14.11%1.11M | -220.51%-3.23M | -0.74%2.63M | 4.47%2.9M | -48.40%976.39K | -63.64%2.68M | -63.02%2.65M |
| Net profit of parent company owners | -29.69%-64.76M | 1,125.09%6.35M | -47.79%4.15M | -329.07%-3.79M | -289.95%-49.93M | -97.52%517.99K | -71.66%7.94M | -89.98%1.65M | -76.96%26.29M | -76.52%20.93M |
| Earning per share | ||||||||||
| Basic earning per share | -30.77%-0.17 | 1,146.15%0.0162 | -50.00%0.01 | -330.95%-0.0097 | -285.71%-0.13 | -97.40%0.0013 | -71.43%0.02 | -89.50%0.0042 | -75.86%0.07 | -78.26%0.05 |
| Diluted earning per share | -30.77%-0.17 | 1,146.15%0.0162 | -50.00%0.01 | -330.95%-0.0097 | -285.71%-0.13 | -97.40%0.0013 | -71.43%0.02 | -89.50%0.0042 | -75.86%0.07 | -78.26%0.05 |
| Other composite income | 1,804.23%21.08M | -150.19%-2.74M | -151.93%-1.75M | -175.89%-937.82K | -114.98%-1.24M | -193.28%-1.09M | -134.53%-695.77K | -468.84%-339.92K | -295.37%-575.37K | -336.71%-372.93K |
| Other composite income of parent company owners | 1,804.23%18.76M | -150.61%-2.44M | -152.59%-1.56M | -175.89%-834.66K | -114.98%-1.1M | -193.28%-973.41K | -134.53%-619.23K | -468.84%-302.53K | -295.37%-512.08K | -336.71%-331.9K |
| Other composite income of minority owners | 1,804.23%2.32M | -146.79%-296.91K | -146.58%-188.72K | -175.89%-103.16K | -114.98%-136.06K | -193.28%-120.31K | -134.53%-76.53K | -468.84%-37.39K | -295.37%-63.29K | -336.71%-41.02K |
| Total composite income | 13.03%-47.31M | 54.91%3.18M | -65.31%3.52M | -257.72%-3.61M | -291.61%-54.39M | -91.15%2.05M | -66.74%10.14M | -87.51%2.29M | -76.60%28.39M | -75.88%23.2M |
| Total composite income of parent company owners | 9.87%-45.99M | 957.76%3.91M | -64.73%2.58M | -442.11%-4.62M | -297.99%-51.03M | -102.21%-455.42K | -73.62%7.32M | -91.79%1.35M | -77.38%25.77M | -76.87%20.6M |
| Total composite income of minority owners | 60.97%-1.31M | -128.84%-723.91K | -66.81%936K | 7.66%1.01M | -228.64%-3.36M | -3.79%2.51M | 2.92%2.82M | -50.20%939K | -64.42%2.61M | -63.55%2.61M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.